TFF Pharmaceuticals Inc (TFFP)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
May 17, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
TFF Pharmaceuticals Cash from Investing (TTM): -0.0948M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0948M |
| September 30, 2023 | -0.1895M |
| June 30, 2023 | -0.9544M |
| March 31, 2023 | -1.414M |
| December 31, 2022 | -1.551M |
| September 30, 2022 | -1.537M |
| June 30, 2022 | -0.901M |
| March 31, 2022 | -0.5296M |
| December 31, 2021 | -0.8685M |
| Date | Value |
|---|---|
| September 30, 2021 | -1.551M |
| June 30, 2021 | -1.703M |
| March 31, 2021 | -1.579M |
| December 31, 2020 | -1.103M |
| September 30, 2020 | -0.2932M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.703M
Minimum
Jun 2021
--
Maximum
Dec 2019
-0.8394M
Average
-0.901M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Lifecore Biomedical Inc | -4.153M |
| Jaguar Health Inc | -- |
| Genprex Inc | -0.0712M |
| Aquestive Therapeutics Inc | -1.022M |
| NovaBay Pharmaceuticals Inc | 1.062M |